NBY News and Press, NovaBay Pharmaceuticals Inc. From 10/28/19

Once-daily system complements Avenova and leverages salesforce calls on eyecare specialists NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces an exclusive 90-...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that it has received approval for the distribution of Avenova from the Australian Government Department of Health a...

Axsome Therapeutics (NASDAQ: AXSM ) initiated with Outperform rating at William Blair. Shares up  1%  premarket. More news on: Axsome Therapeutics, Inc., Canopy Growth Corporation, Minerva Neurosciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Company’s board as an independent director. Dr. Zheng will ch...

NovaBay ® Pharmaceuticals, Inc . (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that management will present at two upcoming investment conferences: RHK Capital 4 th Annual Disruptive Growth C...

NovaBay Pharmaceuticals ( NBY -14.8% ) is down on below-average volume on the heels of its agreement to sell ~4.2M common shares and accompanying unregistered five-year warrants to purchase up to the same number of shares at $1.15 to institutional investors at $1 per share and warrant. C...

EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today announced that it has entered into a securities purchase agreement with...

EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today announced that it has entered into a securities purchase agreement with...

The following slide deck was published by NovaBay Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings Read more ...

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Jason Raleigh – Chief Financial Officer Jody Cain – Investor Relations-LHA Justin Hall – President and Chief Executive Officer Conference Cal...